Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide, Pioglitazone, and Metformin Triple Therapy in New Onset Type 2 Diabetes
NCT01107717Phase 4Completed
- Sponsor
- UT Health San Antonio
- Start
- Jan 2009
- Primary completion
- Feb 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of exenatide in type 2 diabetes mellitus (T2DM), sponsored by UT Health San Antonio. Started Jan 2009; status: completed.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01107717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01107717.